According to the Wall Street Journal, the Department of Justice and the Securities and Exchange Commission are investigating Boston Scientific’s recall of implantable cardioverter defibrillators. Read the article at http://online.wsj.com/article/SB10001424052702304370304575151760074891360.html?mod=WSJ_hpp_sections_business.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder